Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Georges Chedid, M.D.

Concepts (45)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Georges Chedid's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Georges Chedid has written about over time.
Coronavirus Infections, 1 publications between 2020 and 2020, average publication date May 2020. Severe Acute Respiratory Syndrome, 1 publications between 2020 and 2020, average publication date May 2020. Explosions, 1 publications between 2022 and 2022, average publication date February 2022. Students, Medical, 1 publications between 2022 and 2022, average publication date February 2022. Workload, 1 publications between 2022 and 2022, average publication date February 2022. Antibodies, Antiphospholipid, 1 publications between 2022 and 2022, average publication date August 2022. Vaccines, 1 publications between 2022 and 2022, average publication date August 2022. Lebanon, 2 publications between 2022 and 2023, average publication date December 2022. Cognition, 1 publications between 2022 and 2022, average publication date December 2022. Coronary Vessels, 1 publications between 2023 and 2023, average publication date June 2023. Docosahexaenoic Acids, 3 publications between 2022 and 2023, average publication date July 2023. Eicosapentaenoic Acid, 3 publications between 2022 and 2023, average publication date July 2023. Fatty Acids, Omega-3, 4 publications between 2022 and 2024, average publication date August 2023. Coronary Artery Disease, 5 publications between 2022 and 2024, average publication date August 2023. Exercise Tolerance, 2 publications between 2023 and 2024, average publication date October 2023. Calcium, 3 publications between 2023 and 2024, average publication date October 2023. Hydroxymethylglutaryl-CoA Reductase Inhibitors, 1 publications between 2023 and 2023, average publication date November 2023.

To see the data from this visualization as text, click here.
Chedid's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (45)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.